Clinical results and mechanisms of MAGCELL®-therapy in Chemotherapy-induced peripheral neuropathy (CIPN)


Please share this content...
         

Clinical results and mechanisms of MAGCELL®-therapy in Chemotherapy-induced peripheral neuropathy (CIPN)

Back to overview


Tel: +44 (0)115 9167685


This article was written by Dr Jens Reinhold for MLDuk The Journal and has been published in the Jan 2018 issue. It explains the clinical results and mechanism of MAGCELL® MICROCIRC Chemotherapy-induced peripheral neuropathy (CIPN) with scientific references.

To Read/Download Full Article in MLDuk click here (PDF) 

MAGCELL® MICROCIRC can positively influence symptoms of neurotoxicities like sensory ataxia, neuropathy and neuropathic pain symptoms (especially CIPN I-IV) on hands and feet as a result of chemotherapy. Moreover a significant increase in nerve conductivity speed (ulnar nerve) was achieved by the treatment. 

Sufferers are now able to apply this effective treatment at home via the personal unit, due to repeatable short-treatment periods, no side effects and even through textile (including shoes). For pricing and delivery contact info@physioequipment.co.uk - for more product information click here

Clinical results and mechanisms of MAGCELL®-therapy in Chemotherapy-induced peripheral neuropathy (CIPN)   Clinical results and mechanisms of MAGCELL®-therapy in Chemotherapy-induced peripheral neuropathy (CIPN)

Electrode-free electrotherapy also known as MAGCELL®-therapy, arrived in the UK and Ireland in 2017 via exclusive distributors PhysioPod® UK Limited and Physio Equipment.